FUS and sarcoma: Although we did not test this variant, a parallel substitution in the RNA binding protein fused in sarcoma (FUS) (R522G) (Table 2) caused a five-fold decrease in TPNO-1 binding and cytoplasmic mis-localization of FUS27.